(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ARTAX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ARTAX

ST13

US500000088936986

Class

42

Filing

88936986

Registration

6809497

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

08/02/2022

Trademark type

Word

Nice classes

42

Filing date

05/28/2020

Registration date

08/02/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/02/2022

Last transaction

08/02/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2021-07-00

First use in commerce

2021-07-00

Drawing code

4

Owner type

03

Owner location

Cambridge, MA, US

Examiner

GALBO, AMANDA

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ARTAX BIOPHARMA, INC.

Representatives

Aaron Y. Silverstein SAUNDERS & SILVERSTEIN LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development in the pharmaceutical and biotechnology fields

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/02/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

08/02/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/01/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/30/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/29/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/17/2022

IUAF

USE AMENDMENT FILED

06/01/2022

EISU

TEAS STATEMENT OF USE RECEIVED

06/01/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/02/2021

EX2G

SOU EXTENSION 2 GRANTED

11/30/2021

EXT2

SOU EXTENSION 2 FILED

11/30/2021

EEXT

SOU TEAS EXTENSION RECEIVED

11/30/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/29/2021

EX1G

SOU EXTENSION 1 GRANTED

05/27/2021

EXT1

SOU EXTENSION 1 FILED

05/27/2021

EEXT

SOU TEAS EXTENSION RECEIVED

05/27/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/01/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/06/2020

PUBO

PUBLISHED FOR OPPOSITION

10/06/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/16/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/31/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

08/31/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/31/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

08/31/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/31/2020

DOCK

ASSIGNED TO EXAMINER

08/31/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/17/2020

NWAP

NEW APPLICATION ENTERED

06/01/2020

Continuous trademark protection

Get notified about every new filing that threatens ARTAX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.